NEPHROGENEX INC COM
NRX
NRX was delisted on the 10th of May, 2016.
14 hedge funds and large institutions have $14.7M invested in NEPHROGENEX INC COM in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $16.7M → $14.7M (-$1.96M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$570K |
| 2 |
Morgan Stanley
New York
|
+$147K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.2K |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$11K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13.1K |
| 2 |
Citigroup
New York
|
-$684 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCP
1
Rho Capital Partners
New York
| $6.99M | – | – | – |
|
|
VAM
2
Visium Asset Management
New York
| $4.38M | – | – | – |
|
|
3
Morgan Stanley
New York
| $1.19M | +$147K | +19,364 | +12% |
|
|
TI
4
Turner Investments
Berwyn,
Pennsylvania
| $825K | +$11K | +1,454 | +1% |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $588K | +$15.2K | +2,000 | +2% |
|
|
6
Millennium Management
New York
| $498K | +$570K | +75,000 | New |
|
7
Geode Capital Management
Boston,
Massachusetts
| $90K | – | – | – |
|
|
BFA
8
BlackRock Fund Advisors
San Francisco,
California
| $62K | +$8.59K | +1,130 | +14% |
|
9
Bank of America
Charlotte,
North Carolina
| $60K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $4K | -$13.1K | -1,725 | -74% |
|
|
BIM
11
BlackRock Investment Management
Wilmington,
Delaware
| $4K | +$783 | +103 | +18% |
|
|
EWM
12
Edge Wealth Management
New York
| $3K | – | – | – |
|
|
13
Citigroup
New York
| $1K | -$684 | -90 | -42% |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| $1K | +$760 | +100 | +100% |
|
NRX Hedge Fund Activity: Q2 2015 in Review
14 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q2 2015, worth a combined $14.7M — down 12% from $16.7M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NRX positions and 0 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $570K. The largest seller was UBS Group, cutting an estimated $13.1K.
- 14 institutional investors held NEPHROGENEX INC COM (NRX) as of Q2 2015, up from 13 in Q1 2015.
- Funds reported $14.7M of NEPHROGENEX INC COM stock for Q2 2015, down 12% quarter-over-quarter.
- 1 fund opened new NEPHROGENEX INC COM positions in Q2 2015 and 0 closed out, a net change of +1 holder.
- The largest NEPHROGENEX INC COM buyer in Q2 2015 was Millennium Management, an estimated $570K added.
- The largest NEPHROGENEX INC COM seller in Q2 2015 was UBS Group, an estimated $13.1K sold.
Based on aggregated 13F filings for Q2 2015.